Loading [MathJax]/jax/element/mml/optable/BasicLatin.js
Review Topical Sections

Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention

  • Toll-like receptors (TLRs) are essential defensive mediators implicated in immune diseases. Tight regulation of TLR function is indispensable to avoid the damaging effects of chronic signaling. Several endogenous molecules have emerged as negative regulators of TLR signaling. In this review, we highlighted the structure, regulation, and function of RP105 and A20 in negatively modulating TLR-dependent inflammatory diseases, and in fibrosis and potential therapeutic approaches.

    Citation: Swarna Bale, John Varga, Swati Bhattacharyya. Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention[J]. AIMS Allergy and Immunology, 2021, 5(2): 102-126. doi: 10.3934/Allergy.2021009

    Related Papers:

    [1] Ruizhi Yang, Dan Jin . Dynamics in a predator-prey model with memory effect in predator and fear effect in prey. Electronic Research Archive, 2022, 30(4): 1322-1339. doi: 10.3934/era.2022069
    [2] Miao Peng, Rui Lin, Zhengdi Zhang, Lei Huang . The dynamics of a delayed predator-prey model with square root functional response and stage structure. Electronic Research Archive, 2024, 32(5): 3275-3298. doi: 10.3934/era.2024150
    [3] Wenbin Zhong, Yuting Ding . Spatiotemporal dynamics of a predator-prey model with a gestation delay and nonlocal competition. Electronic Research Archive, 2025, 33(4): 2601-2617. doi: 10.3934/era.2025116
    [4] Xiaowen Zhang, Wufei Huang, Jiaxin Ma, Ruizhi Yang . Hopf bifurcation analysis in a delayed diffusive predator-prey system with nonlocal competition and schooling behavior. Electronic Research Archive, 2022, 30(7): 2510-2523. doi: 10.3934/era.2022128
    [5] Yujia Xiang, Yuqi Jiao, Xin Wang, Ruizhi Yang . Dynamics of a delayed diffusive predator-prey model with Allee effect and nonlocal competition in prey and hunting cooperation in predator. Electronic Research Archive, 2023, 31(4): 2120-2138. doi: 10.3934/era.2023109
    [6] Fengrong Zhang, Ruining Chen . Spatiotemporal patterns of a delayed diffusive prey-predator model with prey-taxis. Electronic Research Archive, 2024, 32(7): 4723-4740. doi: 10.3934/era.2024215
    [7] Jiani Jin, Haokun Qi, Bing Liu . Hopf bifurcation induced by fear: A Leslie-Gower reaction-diffusion predator-prey model. Electronic Research Archive, 2024, 32(12): 6503-6534. doi: 10.3934/era.2024304
    [8] San-Xing Wu, Xin-You Meng . Hopf bifurcation analysis of a multiple delays stage-structure predator-prey model with refuge and cooperation. Electronic Research Archive, 2025, 33(2): 995-1036. doi: 10.3934/era.2025045
    [9] Jiange Dong, Xianyi Li . Bifurcation of a discrete predator-prey model with increasing functional response and constant-yield prey harvesting. Electronic Research Archive, 2022, 30(10): 3930-3948. doi: 10.3934/era.2022200
    [10] Chen Wang, Ruizhi Yang . Hopf bifurcation analysis of a pine wilt disease model with both time delay and an alternative food source. Electronic Research Archive, 2025, 33(5): 2815-2839. doi: 10.3934/era.2025124
  • Toll-like receptors (TLRs) are essential defensive mediators implicated in immune diseases. Tight regulation of TLR function is indispensable to avoid the damaging effects of chronic signaling. Several endogenous molecules have emerged as negative regulators of TLR signaling. In this review, we highlighted the structure, regulation, and function of RP105 and A20 in negatively modulating TLR-dependent inflammatory diseases, and in fibrosis and potential therapeutic approaches.



    The interaction between predator and prey is one of the most important topics in mathematical biology and theoretical ecology [1]. The direct interaction, which is reflected by predation, has been extensively studied [2,3,4,5]. Recently, a field experimental study [6] provided evidence that show that indirect effect (e.g., fear effect) cannot be ignored. Even though there is no direct killing between predators and prey, the presence of predators cause a reduction in prey population [6,7]. To explore the impact that fear can have on population dynamics, Wang et al. [8] formulated the following model incorporating the cost of fear

    {dudt=f(k,v(t))r0u(t)du(t)au2(t)g(u(t))v(t),dvdt=cg(u(t))v(t)mv(t), (1.1)

    where u and v are the population densities of the prey and predator, respectively. Function f(k,v(t)) reflects the cost of anti-predation response due to fear, where k measures the level of fear. r0 is the reproduction rate of prey in the absence of predator, d and m represent the natural death rate, a reflects the death rate due to intra-specific competition, the positive constant c is the efficiency in biomass transfer, g(u(t)) is the functional response. After their work, other biological phenomena, such as the Allee effect, harvesting, cooperation hunting, prey refuge, group defense and so on, were introduced into predator-prey models with the fear effect [1,9,10,11,12,13,14,15].

    In fact, besides the cost in the reproduction of prey due to fear, there are also some benefits for an anti-predation response. Wang and Zou [16] described such benefits with g(u(t),k) instead of g(u(t)), and considered both linear functional response and Holling type II functional response. In the model with the Holling type II functional response, they choose g(u(t),k)=11+c1kpu(t)1+qu(t), f(k,v)=11+c2kv(t) and get the following model

    {dudt=r0u(t)1+c2kv(t)du(t)au2(t)pu(t)v(t)1+qu(t)11+c1k,dvdt=pu(t)v(t)1+qu(t)c1+c1kmv(t), (1.2)

    where c1,c2 represent the decreasing rate of reproduction and predation, respectively.

    To obtain more resources, species tend to migrate from a high population density area to a low population density area. Therefore, spatial diffusion should be considered when we model the interaction between predator and prey. Many diffusive models have been proposed to investigate the influence of the cost of fear on the spatial distribution of species [17,18,19,20]. Wang and Zou [21] proposed a reaction-diffusion-advection predator prey model, in which conditions of spatial pattern formation are obtained.

    In reality, there are time delays in almost every process of predator and prey interaction. Many kinds of delays have been incorporated into predator-prey models with the fear effect [16,17,18,22,23,24,25]. Since the biomass transfer is not instantaneous after the predation of prey, the biomass transfer delay is considered in [16]. A generation time delay in prey has been considered in [23]. In fact, the reproduction of prey will not respond immediately to fear, but will rather reduce after a time lag. Such a fear response delay has been considered in [18,24,25].

    Motivated by [16] and the previous work, we propose the following model

    {tu(x,t)=d1Δu(x,t)+r0u(x,t)1+c2kv(x,tτ)du(x,t)au2(x,t)pu(x,t)v(x,t)1+qu(x,t)11+c1k,x(0,lπ),t>0,tv(x,t)=d2Δv(x,t)+pu(x,t)v(x,t)1+qu(x,t)c1+c1kmv(x,t),x(0,lπ),t>0,ux(0,t)=ux(lπ,t)=vx(0,t)=vx(lπ,t)=0,t>0,u(x,t)=u0(x,t)0,v(x,t)=v0(x,t)0,x(0,lπ),t[τ,0], (1.3)

    where d1,d2>0 represent the diffusion coefficients of prey and predator, respectively, and τ is the fear response delay in prey reproduction.

    Although there have been some literature on a predator-prey model with fear effect and delay, no work has been done to explore the joint impact of fear level and fear response delay on the population dynamics. In this paper, we aim to reveal how these two parameters k and τ jointly affect the dynamics of system (1.3) from the view of bifurcation analysis. The characteristic equation may have no, one or two pairs of purely imaginary roots under different conditions. Correspondingly, the fear response delay may have no effect, both stabilizing and destabilizing effect, or destabilizing effect on the stability of the positive equilibrium. By the discussion of the monotonicity of the critical values of Hopf bifurcation, we get the order of all the Hopf bifurcation values. We prove the existence of stability switches for system (1.3) under suitable condition. Through numerical simulations, we find that the level of fear k has a crucial role in the stability of positive equilibrium and the occurrence of Hopf bifurcation induced by fear response delay. To reveal the complex phenomena induced by k and τ, double Hopf bifurcation analysis is carried out, which can induce complex spatio-temporal dynamics [26,27]. It provides a qualitative classification of dynamical behaviors on the (k,τ) plane, which can help us to explicitly observe the different dynamics corresponding to different values of k and τ, including quasi-periodic oscillations on two or three dimensional torus, and even chaos.

    The rest of this paper is organized as follows. In Section 2, we analyze the local stability of equilibria and obtain the condition of Hopf bifurcation in three different cases. In Section 3, we give the condition for double Hopf bifurcation and derive the normal form of the double Hopf bifurcation. In Section 4, numerical simulations are presented to verify our theoretical results. Finally, conclusions and discussions are given in Section 5.

    In this section, we discuss the local stability of equilibria. System (1.3) has three possible equilibria. The trivial equilibrium E0(0,0) always exists. When r0d>0, system (1.3) has a predator-free equilibrium Eu(r0da,0). Moreover, if

    (H1)0<m(1+c1k)pcmq(1+c1k)<r0da

    holds, there is a unique positive equilibrium E(u,v), where

    u=m(1+c1k)pcmq(1+c1k),v=a1+a214a0a22a0, (2.1)

    with

    {a0=c2pk,a1=p+(d+au)(1+qu)(1+c1k)c1k,a2=(d+aur0)(1+qu)(1+c1k). (2.2)

    It is well known that the laplacian operator Δ has eigenvalues n2/l2(n=0,1,2,).

    Now, we study the local stability for each of equilibria. The linearization of system (1.3) at an equilibrium (ˉu,ˉv) can be written as

    t(u(x,t)v(x,t))=D(Δu(x,t)Δv(x,t))+G0(u(x,t)v(x,t))+G1(u(x,tτ)v(x,tτ)), (2.3)

    where

    D=(d100d2),G0=(J11J12J21J22),G1=(0K1200),

    with

    J11=r01+c2kˉvd2aˉupˉv(1+c1k)(1+qˉu)2,J12=pˉu(1+c1k)(1+qˉu),J21=cpˉv(1+c1k)(1+qˉu)2,J22=cpˉu(1+qˉu)(1+c1k)m,K12=r0c2kˉu(1+c2kˉv)2.

    The characteristic equation is given by

    det(λ+d1n2l2J11 J12K12eλτJ21 λ+d2n2l2J22)=0,n=0,1,2,. (2.4)

    From (2.4), we get the corresponding characteristic equation at E0(0,0) as

    (λ+d1n2l2r0+d)(λ+d2n2l2+m)=0,n=0,1,2,.

    Thus, we have

    λ1,n=d1n2l2+r0d,λ2,n=d2n2l2m,n=0,1,2,.

    Obviously, λ2,n<0. If r0<d, λ1,n<0 for all nN0, and if r0>d, λ1,0>0. Thus, if r0<d, E0 is locally asymptotically stable. If r0>d, E0 is unstable.

    If r0>d, the predator-free equilibrium Eu(r0da,0) exists. The corresponding characteristic equation is given by

    (λ+d1n2l2+r0d)(λ+d2n2l2+mcp(r0d)(1+c1k)[a+q(r0d)])=0,n=0,1,2,.

    Since r0d>0, λ1,n=d1n2l2(r0d)<0. Now we consider the sign of λ2,n=[d2n2l2+mcp(r0d)(1+c1k)[a+q(r0d)]]. If (H1) holds, λ2,0=m+cp(r0d)(1+c1k)[a+q(r0d)]>0, which indicates that Eu is unstable. If m(1+c1k)pcmq(1+c1k)>r0da>0 holds, λ2,n<0 for all nN0, and Eu is locally asymptotically stable.

    Theorem 1. (i) When r0<d, there is only the trivial equilibrium E0 for system (1.3), which is locally asymptotically stable; when r0>d, E0 is unstable and there is a predator-free equilibrium Eu.

    (ii) When m(1+c1k)pcmq(1+c1k)>r0da>0, Eu is locally asymptotically stable; When (H1) holds, Eu is unstable and there is a positive equilibrium E.

    For the positive equilibrium E(u,v) of system (1.3), we have

    J11=au+pquv(1+c1k)(1+qu)2,J12=pu(1+c1k)(1+qu)<0,J21=cpv(1+c1k)(1+qu)2>0,J22=0,K12=r0c2ku(1+c2kv)2<0. (2.5)

    The characteristic equation becomes

    λ2+Tnλ+Dn+Meλτ=0,n=0,1,2,, (2.6)

    where

    Tn=(d1+d2)n2l2J11,Dn=d1d2n4l4J11d2n2l2J21J12,M=J21K12>0.

    When τ=0, the characteristic equation (2.6) becomes

    λ2+Tnλ+Dn+M=0,n=0,1,2,. (2.7)

    Obviously, D0+M=J21J12J21K12>0. Hence, if

    (H2)J11=au+pquv(1+c1k)(1+qu)2<0

    holds, we have  Tn>0, Dn+M>0 for all nN0, thus all roots of Eq (2.7) have negative real parts. If J11>0, we have T0<0 and D0+M>0, the roots of (2.7) have positive real parts when n=0, which means that E is unstable in the absence of diffusion. To sum up, Turing instability induced by diffusion will not occur.

    In the following, we assume that (H2) always holds, which ensures  Tn>0, Dn>0 and Dn+M>0. Thus, a change of stability at E(u,v) can only happen when there is at least one root of Eq (2.6) across the imaginary axis on the complex plane. After excluding Turing instability induced by diffusion, now we seek the critical values of τ where the roots of Eq (2.6) will cross the imaginary axis from the left half plane to the right half plane. Plugging λ=iωn(ωn>0) into Eq (2.6), we obtain

    ω2n+Tniωn+Dn+M(cosωnτisinωnτ)=0.

    Separating the real and imaginary parts, we obtain

    {cos(ωnτ)=ω2nDnM=Cn(ωn),sin(ωnτ)=TnωnM=Sn(ωn). (2.8)

    Squaring and adding both equations of (2.8), we have

    ω4n+(T2n2Dn)ω2n+D2nM2=0. (2.9)

    The number of positive roots of Eq (2.9) is relevant to the signs of T2n2Dn and D2nM2. For the convenience of discussion, we make the following assumptions.

    (H3)T202D00 and D0M0.(H4)T202D0<0 and D0M>0.(H5)T202D0<0 and D0M=0.(H6)T202D00 and D0M<0.(H7)T202D0<0 and D0M<0.

    Before the discussion of these cases, we need to investigate some properties of T2n2Dn and D2nM2.

    Lemma 1. Suppose that (H1) and (H2) hold. T2n2Dn and D2nM2 are both monotonically increasing with respect to n.

    Proof. When (H2) holds, we have

    d(T2n2Dn)dn=2(TndTndndDndn)=2(d212n3l4+d222n3l4J11d12nl2)>0,

    which means that T2n2Dn is monotonically increasing with respect to n. Similarly, when J11<0, we have Dn>0, and

    d(D2nM2)dn=2DndDndn=2Dn(d1d24n3l4J11d22nl2)>0.

    We first consider the case when (H3) holds.

    Lemma 2. If (H1), (H2) and (H3) hold, then all roots of Eq (2.6) have negative real parts for all τ0.

    Proof. Noticing that Dn+M>0 for all nN0, thus D0M0 leads to D20M20. From Lemma 1 and (H3), we can deduce that T2n2Dn0 and D2nM20 for all nN0. Therefore, Eq (2.9) has no positive roots, and Eq (2.6) has no imaginary roots.

    Theorem 2. If (H1), (H2) and (H3) hold, the positive equilibrium E is locally asymptotically stable for all τ0.

    Lemma 3. If (H1), (H2) and (H4) hold, there exists n1N0 such that the following conclusions hold.

    (i) If either n>n1 or 0nn1 and Δ=(T2n2Dn)24(D2nM2)<0, then all roots of Eq (2.6) have negative real parts for all τ0.

    (ii) If Δ>0 for 0nn1, then Eq (2.6) has a pair of imaginary roots ±iω+n(±iωn, respectively) for 0nn1.

    Proof. Similar as the proof in Lemma 2, we have D2nM2>0 for all nN0. When T202D0<0, from Lemma 1, there exists n1N0 such that

    {T2n2Dn0,n>n1,T2n2Dn<0,0nn1. (2.10)

    It means that Eq (2.9) has no positive roots for n>n1. For 0nn1, if Δ=(T2n2Dn)24(D2nM2)<0, Eq (2.9) has no positive roots, and if Δ>0, Eq (2.9) has two positive roots ω±n, where

    ω±n=[12(2DnT2n±Δ)]12. (2.11)

    Correspondingly, Eq (2.6) has a pair of purely imaginary roots ±iω+n(±iωn,respectively) for 0nn1.

    Since (H2) holds, we have Tn>0. Noticing that M=J21K12>0, from (2.8), we have Sn(ω±n)>0, and we get

    τj±n=1ω±n(arccos[(ω±n)2DnM]+2jπ),0nn1,j=0,1,2,. (2.12)

    Lemma 4. Assume that (H1), (H2) and (H4) hold. If Δ>0, then Re[dλdτ]τ=τj+n>0, Re[dλdτ]τ=τjn<0, for 0nn1, j=0,1,2,, where n1 is defined in (2.10).

    Proof. Differentiating two sides of (2.6) with respect to τ, we obtain

    Re[dλdτ]1τ=τj±n=2ω±ncos(ω±nτ)+Tnsin(ω±nτ)Mω±n=2ω±n(ω±2nDn)+T2nω±nM2ω±n=±ΔM2.

    The sign of Re[dλdτ]τ=τj±n is the same as that of Re[dλdτ]1τ=τj±n, thus we have Re[dλdτ]τ=τj+n>0, Re[dλdτ]τ=τjn<0.

    Now we consider the order of the critical values Hopf bifurcation.

    Lemma 5. Assume that (H1), (H2) and (H4) hold, and Δ>0 for 0nn1. τj+n is monotonically increasing and τjn is monotonically decreasing with respect to n (0<nn1), where n1 and τj±n are defined in (2.10) and (2.12), respectively.

    Proof. See Appendix A.

    Theorem 3. Assume that (H1), (H2) and (H4) hold, and n1 is defined in (2.10).

    (i) If Δ<0 for 0nn1, E is locally asymptotically stable for all τ>0.

    (ii) If Δ>0 for 0nn1, system (1.3) undergoes a Hopf bifurcation at E when τ=τj±n(0nn1,j=0,1,2,). Moreover, E is locally asymptotically stable when τ[0,τ0+0)(τ00,τ1+0)(τ(s1)0,τs+0), and it is unstable when τ(τ0+0,τ00)(τ1+0,τ10)(τs+0,+).

    Proof. (ⅰ) From Lemma 3, when Δ<0, Eq (2.6) has no purely imaginary roots, thus the stability of E can not be changed by delay.

    (ⅱ) When Δ>0, from Lemma 5, we have τj+0<τj+1<<τj+n1, and τjn1<<τj0,j=0,1,2,. From ω+n1>ωn1, we have arccos[(ω+n1)2Dn1M]<arccos[(ωn1)2Dn1M], and τj+n1<τjn1. Therefore, τj+0<<τj+n1<τjn1<<τj0.

    We claim that there exists a positive integer s such that τ0+0<τ00<τ1+0<τ10<<τs+0<τ(s+1)+0<τs0. Since ω0<ω+0, τj+0τ(j1)+0=2πω+0<τj0τ(j1)0=2πω0, which means that the alternation for τj+0 and τj0 cannot persist for the entire sequence, and there exists a positive integer s such that τ(s1)+0<τ(s1)0<τs+0<τ(s+1)+0<τs0. From Lemma 4, we can get the stable and unstable interval for τ.

    First, we consider the case when (H5) holds. If (H5) holds, Eq (2.9) has a positive root ω+0=2D0T20 when n=0. Similar as Lemma 3, there exists n1N0 such that (2.10) holds. If Δ>0 for 0<nn1, Eq (2.6) has a pair of imaginary roots ±iω+n(±iωn,respectively) for 0<nn1.

    Lemma 6. If (H1), (H2) and (H5) hold, there exists n1N0 defined in (2.10).

    (i) If either n>n1 or 0<nn1 and Δ<0, then all roots of Eq (2.6) have negative real parts for all τ0.

    (ii) If n=0, then Eq (2.6) has a pair of imaginary roots ±iω+0.

    (iii) If Δ>0 for 0<nn1, then Eq (2.6) has a pair of imaginary roots ±iω+n(±iωn, respectively) for 0<nn1.

    Remark 1. Similar as the proof of Lemma 5 and Theorem 3, we can get τj+0<τj+1<<τj+n1<τjn1<<τj1, where τj±n is defined in (2.12). Similar as Lemma 4, we can verify that Re[dλdτ]τ=τj+n>0 for 0nn1 and Re[dλdτ]τ=τjn<0 for 0<nn1. Being different from case II, stability switches can not happen.

    Now we consider the case when (H6) holds. From Lemma 1, and T202D00, we have T2n2Dn0 for all nN0. From Lemma 1, combining D0M<0 with Dn+M>0, we get

    D2nM2{0,n>n2,<0,0nn2. (2.13)

    Equation (2.9) has only one positive root ω+n for 0nn2, where

    ω+n=[12(2DnT2n+Δ)]12.

    Lemma 7. Assume that (H1), (H2) and (H6) hold, and n2N0 is defined in (2.13).

    (i) If n>n2, then all roots of Eq (2.6) have negative real parts for all τ0.

    (ii) If 0nn2, then Eq (2.6) has a pair of imaginary roots ±iω+n for 0nn2.

    It is easy to get Sn(ω+n)>0, from (2.8), we have

    τj+n=1ω+n(arccos[(ω+n)2DnM]+2jπ),0nn2,j=0,1,2,. (2.14)

    When (H7) holds, from Lemma 1, we can deduce that there exists n1 and n2 such that

    T2n2Dn{0,n>n1,<0,0nn1,D2nM2{0,n>n2,<0,0nn2. (2.15)

    If n1n2, Eq (2.9) has only one positive root ω+n for 0nn2, where

    τj+n=1ω+n(arccosCn(ω+n)+2jπ),0nn2,j=0,1,2,,

    and Eq (2.9) has no positive roots for n>n2.

    If n2n1, Eq (2.9) has one positive root ω+n for 0nn2, and has two positive roots ω±n for n2+1<nn1, and has no positive roots for n>n1. When n=n2+1, if D2n2+1M2>0, Eq (2.9) has two positive roots ω±n2+1, and if D2n2+1M2=0, Eq (2.9) has one positive root ω+n2+1. Similar as the proof in Lemma 5, we have

    {τj+0<<τj+n2<τj+n2+1<<τj+n1<τjn1<<τjn2+2<τjn2+1,if D2n2+1M2>0,τj+0<<τj+n2<τj+n2+1<<τj+n1<τjn1<<τjn2+2,if D2n2+1M2=0,

    where

    {τj+n=1ω+n(arccosCn(ω+n)+2jπ),0nn2,j=0,1,2,,τj±n=1ω±n(arccosCn(ω±n)+2jπ),n2+1<nn1,j=0,1,2,,τj+n2+1={1ω±n2+1(arccosCn2+1(ω±n2+1)+2jπ),ifD2n2+1M2>0,j=0,1,2,,1ω+n2+1(arccosCn2+1(ω+n2+1)+2jπ),ifD2n2+1M2=0,j=0,1,2,.

    For either n1n2 or n2n1, we have

    τ0+0=min (2.16)

    From the previous discussion, we can get the following conclusions.

    Theorem 4. Assume that and hold, and , are defined in (2.15). If , or holds, is locally asymptotically stable when , and is unstable when .

    Proof. If , or holds, we easily know that is the smallest critical value of Hopf bifurcation values. Similar as Lemma 4, we can get the transversality condition, which can lead to the results.

    In order to figure out the joint effect of fear level and fear response delay on the dynamical behavior of system (1.3), we carry out double Hopf bifurcation analysis. We first verify the condition for the occurrence of double Hopf bifurcation.

    Remark 2. Assume that , and hold. If there exists such that . Then system (1.3) may undergo a double Hopf bifurcation at the positive equilibrium when .

    Define the real-valued Hilbert space , and the corresponding complex space . Let , , and drop the hats for the convenience of notation. Denote , and . System (1.3) can be written as

    (3.1)

    where the coefficients of nonlinear terms , etc., are in Appendix B, and

    Here , and are defined in (2.5), in which are functions of defined in (2.1).

    Let , , then is a double Hopf bifurcation point. System (3.1) can be written as

    (3.2)

    where

    with

    and

    We leave the detailed calculation and some expressions in Appendix C.

    Define an enlarged phase space by

    Equation (3.2) can be written as an abstract ordinary differential equation in

    (3.3)

    where , with

    It is obvious that are the pure imaginary eigenvalues of the operator and the corresponding eigenfunctions in are , respectively, where

    and , , , , with

    A direct calculation derived that , are the formal adjoint eigenvectors of , and satisfy , . Here

    and are the adjoint bilinear form

    with a function of bounded variation are given by

    Denote

    where , .

    Now we decompose into the direct sum of the central subspace and its complementary space

    (3.4)

    where is the projection defined by

    According to (3.4), can be decomposed as

    where , and .

    Then system (3.3) in is equivalent to the system

    where is the restriction of on , for , and and are in Appendix D.

    According to [28], we can obtain the normal form of the double Hopf bifurcation up to the third order as follows

    (3.5)

    Here

    where

    with

    In this section, we carry out some numerical simulations to explain the theoretical results obtained in the previous sections. Symbolic mathematical software Matlab is used to plot numerical graphs. The delayed reaction-diffusion system (1.3) is numerically solved by transforming the continuous system to discrete system using discretization of time and space. In the discrete system, the Laplacian describing diffusion is calculated using finite differences, and the time evolution is solved using the Euler method. Fix the parameters as

    (4.1)

    From Theorems 2, 3, 4, we have found that the fear response delay may have no effect, both stabilizing and destabilizing effect, or destabilizing effect on the stability of , respectively. In this section, we explore that the impact level of fear has on the stability of the positive equilibrium and the occurrence of Hopf bifurcation induced by fear response delay.

    Choose , such that the level of fear is low. We can verify that holds, thus exists. Moreover, and hold, which indicates that is locally asymptotically stable for all from Theorem 2. This indicates that the fear response delay does not change the stability of the positive equilibrium, which means that the fear response delay cannot support periodic oscillations in prey and predator populations with a low level of fear.

    When is increased to , the positive equilibrium still exists, and , and hold. By calculating the critical value of Hopf bifurcation in Table 1, we can get . From Theorem 3, is locally asymptotically stable when (see Figures 1 and 3), and it is unstable when (see Figures 2 and 4). It means that the fear response delay may lead to stability switches with an intermediate level of fear, which is not observed in the model with biomass transfer delay in [16].

    Table 1.  Critical values of Hopf bifurcation .

     | Show Table
    DownLoad: CSV
    Figure 1.  The positive equilibrium is asymptotically stable when .
    Figure 2.  is unstable and there is a bifurcating periodic solution when .
    Figure 3.  The positive equilibrium is asymptotically stable when .
    Figure 4.  is unstable and there is a bifurcating periodic solution when .

    When is further increased to , we can verify that , and hold, and we get . From Theorem 4, is locally asymptotically stable when , and it is unstable when .

    In this section, we explore the joint effect of the fear level and fear response delay on the dynamics of system (1.3). We choose and as bifurcation parameters, and other parameters are the same as in (4.1). From (2.12), we can draw Hopf bifurcation curves with varying (see Figure 5). Hopf bifurcation curve intersects with at HH . On HH, Eq (2.6) has two pairs of purely imaginary roots . Therefore, HH is a possible double Hopf bifurcation point. By the calculation of normal form of double Hopf bifurcation, we can get the coefficients in (3.5) with

    Figure 5.  The bifurcation diagram on plane.

    Make the polar coordinate transformation

    and denote

    Removing the bars, the four-dimensional system (3.5) is transformed into the following two-dimensional amplitude system

    (4.2)

    By a simple calculation, we find that the system (4.2) admits the following equilibria

    According to [29], the unfolding of system (4.2) is of type VIa. There are rays near the bifurcation point, which divide the phase space into eight parts (see Figure 6(a)), where

    Figure 6.  (a) The bifurcation diagram on plane. (b) The complete bifurcation set around HH.

    The detailed dynamics in near have shown in Figure 6(b).

    Notice that of (4.2) corresponds to the positive equilibrium of the original system (1.3). and correspond to the periodic solution of (1.3). corresponds to quasi-periodic solution on a 2-torus. Periodic orbit of (4.2) corresponds to quasi-periodic solution on a 3-torus. Due to the fact that double Hopf bifurcation point HH is the intersection of 0-mode Hopf bifurcation curves and , all periodic or quasi-periodic solutions near HH are spatially homogeneous.

    In region , system (4.2) has only one equilibrium , which is a saddle. It means that the positive equilibrium of system (1.3) is unstable.

    In region , the trivial equilibrium of (4.2) is a sink, and is unstable. This means that of system (1.3) is asymptotically stable as shown in Figure 7, when and are chosen in . In addition, the spatially homogeneous periodic solution is born, which is unstable.

    Figure 7.  When in , the positive equilibrium is asymptotically stable.

    In region , system (4.2) has three equilibria: , and . is stable while other equilibria are unstable. When and are chosen in , system (1.3) has spatially homogeneous periodic solution, which is stable (see Figure 8).

    Figure 8.  When in , the periodic solutions are stable.

    In region , there are four equilibria of (4.2): , , and . is stable while other equilibria are unstable. Since the double Hopf bifurcation occurs at the intersection of two Hopf bifurcation curves with , we choose to demonstrate the rich dynamical phenomena of system (1.3). When parameters are chosen as and in , system (1.3) has a quasi-periodic solution on 2-torus, which is shown in Figure 9.

    Figure 9.  There is a stable quasi-periodic solution on a 2-torus of system (1.3) when .

    In region , there are four equilibria and a periodic orbit of (4.2). , , and are all unstable, and the periodic orbit is stable. This means that system (1.3) has a stable quasi-periodic solution on a 3-torus. Figure 10 illustrates the existence of a stable quasi-periodic solution on a 3-torus when and are chosen in .

    Figure 10.  There is a stable quasi-periodic solution on a 3-torus of system (1.3) when .

    In region , system (4.2) has four equilibria: , , and , which are all unstable. When the parameter enters region , the 3-torus disappears through heteroclinic orbits, and the system (1.3) generates strange attractor according to the "the Ruelle-Takens-Newhouse" scenario. Figure 11 illustrates system (1.3), which demonstrates chaotic phenomena when and are chosen in . The right figures of Figure 9, 10 and 11 are the results of Poincaré map on a Poincaré section.

    Figure 11.  When , the system has chaotic behavior and there is a strange attractor of system (1.3).

    In region , system (4.2) has three equilibria: , and , which are all unstable. This means that the positive equilibrium and the spatially homogeneous periodic solutions of system (1.3) are all unstable.

    In region , system (4.2) has two equilibria: and , which are both unstable. This means that the positive equilibrium and the spatially homogeneous periodic solution of system (1.3) are all unstable.

    There have been more and more evidences showing that fear from the predator may affect the behavior and physiology of prey, which could reduce the reproduction of prey [1,6,7]. Moreover, anti-predation behavior of scared prey can also reduce the chance of prey being caught by predators. Therefore, we consider a predator-prey model with both costs and benefits due to fear based on [16]. Since the cost of fear in prey reproduction is not instantaneous, we incorporate a fear response delay into the model. Our aim is to explore how the fear level and fear response delay jointly affect the dynamics of the predator-prey system from the point of view of both codimension-1 and codimension-2 bifurcation analysis.

    First, we find that Turing instability does not occur in our model. Since the pioneering work of Turing [30], quite a number of literature has revealed that diffusion might destabilize an equilibrium and generate spatial pattern formation. However, not all diffusive systems exhibit such diffusion-driven instability. In some chemical and biological models, Turing instability induced by diffusion are not observed [31,32,33].

    Next, we explore the role of fear response delay on the dynamics. Through the analysis of the characteristic equation, it turns out that there are three different cases: the fear response delay may have no effect, both stabilizing and destabilizing effect, or destabilizing effect on the stability of , which are shown in Theorems 2, 3, 4, respectively. Combining with numerical simulations, it is found that the the occurrence of Hopf bifurcation induced by fear response delay has closely connection with the fear level. When the fear level is low, the delay could not change the stability of the positive equilibrium, which is asymptotically stable for all . From the point of view of biology, the fear response delay cannot support periodic oscillations in prey and predator populations with a low level of fear. When the fear level is in an intermediate range, the fear response delay can induce stability switches, which indicates that the delay has effects on both destabilizing and stabilizing the dynamics. It is observed that such stability switches cannot be generated by the biomass transfer delay [16]. When the fear level is high, the fear response delay can destabilize the equilibrium and induce Hopf bifurcation.

    Finally, to better reveal the joint effect of fear level and fear response delay on the dynamics of system (1.3), we carry out codimension-2 bifurcation analysis. On the plane, by finding the interactions of Hopf bifurcation curves, we can find the possible critical point of double Hopf bifurcation. After the calculation of the normal form for double Hopf bifurcation, we can obtain the bifurcation set, and figure out all the dynamical behaviors around the critical point. There are periodic solutions, quasi-periodic solutions and even chaos observed near the double Hopf bifurcation point.

    In this paper, we assume that the interaction between individuals of a species is local. The individuals at different locations may compete for common resource or communicate visually or by chemical means. Regarding fear effect, the fear of predator depends on both the local and nearby appearance of the predator. Taking these into account, the influence of the nonlocal effect on the spatiotemporal dynamics of the diffusive predator-prey model with fear would be worth further study. In addition, we consider diffusion induced by random movement, however, cognition and memory also have an important influence on the animal movement. Shi et al. [34] proposed a memory-based diffusion equation of a single species. Memory-based diffusion can be modified and applied to the model with fear effect, which will provide much more realistic results and bring mathematical challenges.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    The work is supported by National Natural Science Foundation of China (Nos. , and ) and PhD research startup foundation of Shaanxi University of Science and Technology (2023BJ-13).

    The authors declare there is no conflicts of interest.

    By direct calculation, we have

    From Lemma 1, we have , . Moreover, from (2.10), we know that for . Combining and , we have , and . Similarly, we can also prove that . Thus, is monotonically increasing with respect to .

    Now we consider the monotonicity for .

    Since for all , and for , then for . Combining with Lemma 1, we have . From , and , we have , and thus . From , we get . Therefore, , and . can also lead to . Thus, is monotonically decreasing with respect to .

    From the expression of ,

    where

    with , , , ,

    Here are linear operators and

    where

    and

    Denote .


    Acknowledgments



    We are grateful for helpful discussions with Drs Benjamin Korman, Warren Tourtellotte, Bettina Shock, Christian Stehlik, Feng Fan, Kim Midwood, Averil Ma, Christopher Karp and members of the Varga Lab. Supported by grants from the National Institutes of Health (AR42309) and the Scleroderma Foundation.

    Conflict of interest



    All authors declare no conflicts of interest in this paper.

    [1] Medzhitov R, Preston-Hurlburt P, Janeway CA (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397. doi: 10.1038/41131
    [2] Stoffels JMJ, Zhao C, Baron W (2013) Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build. Cell Mol Life Sci 70: 4243-4253. doi: 10.1007/s00018-013-1350-0
    [3] Bhattacharyya S, Wang W, Morales-Nebreda L, et al. (2016) Tenascin-C drives persistence of organ fibrosis. Nat Commun 7: 1-14.
    [4] Huang QQ, Sobkoviak R, Jockheck-Clark AR, et al. (2009) Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol 182: 4965-4973. doi: 10.4049/jimmunol.0801563
    [5] Huang QQ, Pope RM (2010) Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis. J Leukocyte Biol 88: 253-262. doi: 10.1189/jlb.0310126
    [6] Vencken SF, Greene CM (2016) Toll-like receptors in cystic fibrosis: impact of dysfunctional microRNA on innate immune responses in the cystic fibrosis lung. J Innate Immun 8: 541-549. doi: 10.1159/000444687
    [7] Bhattacharyya S, Wang W, Qin W, et al. (2018) TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung. JCI Insight 3: e98850. doi: 10.1172/jci.insight.98850
    [8] Divanovic S, Trompette A, Atabani SF, et al. (2005) Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. J Endotoxin Res 11: 363-368. doi: 10.1177/09680519050110061201
    [9] Gon Y, Asai Y, Hashimoto S, et al. (2004) A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells. Am J Resp Cell Mol 31: 330-336. doi: 10.1165/rcmb.2003-0438OC
    [10] Peng J, Tao X, Li R, et al. (2015) Novel toll/IL-1 receptor homologous region adaptors act as negative regulators in amphioxus TLR signaling. J Immunol 195: 3110-3118. doi: 10.4049/jimmunol.1403003
    [11] Divanovic S, Trompette A, Petiniot LK, et al. (2007) Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105. J Leukocyte Biol 82: 265-271. doi: 10.1189/jlb.0107021
    [12] Zhao X, Chu Q, Cui J, et al. (2018) MicroRNA-19a as a negative regulator in TLR signaling pathway by direct targeting myeloid differentiation factor 88 in miiuy croaker. Dev Comp Immunol 87: 171-175. doi: 10.1016/j.dci.2018.06.009
    [13] Xu M, Li D, Yang C, et al. (2018) MicroRNA-34a inhibition of the TLR signaling pathway via CXCL10 suppresses breast cancer cell invasion and migration. Cell Physiol Biochem 46: 1286-1304. doi: 10.1159/000489111
    [14] Xie J, Zhang L, Fan X, et al. (2019) MicroRNA-146a improves sepsis-induced cardiomyopathy by regulating the TLR-4/NF-κB signaling pathway. Exp Ther Med 18: 779-785.
    [15] Curtale G, Mirolo M, Renzi TA, et al. (2013) Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. P Natl Acad Sci USA 110: 11499-11504. doi: 10.1073/pnas.1219852110
    [16] Jung WJ, Lee SY, Choi SI, et al. (2018) Toll-like receptor expression in pulmonary sensory neurons in the bleomycin-induced fibrosis model. PLoS One 13: e0193117. doi: 10.1371/journal.pone.0193117
    [17] Stärkel P, Schnabl B, Leclercq S, et al. (2019) Deficient IL-6/stat3 signaling, high TLR7, and type I interferons in early human alcoholic liver disease: A triad for liver damage and fibrosis. Hepatol Commun 3: 867-882. doi: 10.1002/hep4.1364
    [18] Castellano G, Stasi A, Franzin R, et al. (2019) LPS-binding protein modulates acute renal fibrosis by inducing pericyte-to-myofibroblast trans-differentiation through TLR-4 signaling. Int J Mol Sci 20: 3682. doi: 10.3390/ijms20153682
    [19] Cáceres FT, Gaspari TA, Samuel CS, et al. (2019) Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts. FASEB J 33: 14717-14733. doi: 10.1096/fj.201901079RR
    [20] Liu AJ, Wu PC, Ciou JR, et al. (2021) Differential expression of Toll-like receptors 1 and 3 in patients with systemic lupus erythematosus and systemic sclerosis. Research Square In press.
    [21] Bhattacharyya S, Varga J (2015) Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis. Curr Rheumatol Rep 17: 2. doi: 10.1007/s11926-014-0474-z
    [22] Beutler B (2009) Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 227: 248-263. doi: 10.1111/j.1600-065X.2008.00733.x
    [23] West AP, Koblansky AA, Ghosh S (2006) Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 22: 409-437. doi: 10.1146/annurev.cellbio.21.122303.115827
    [24] Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650. doi: 10.1016/j.immuni.2011.05.006
    [25] Kumar H, Kawai T, Akira S (2011) Pathogen recognition by the innate immune system. Int Rev Immunol 30: 16-34. doi: 10.3109/08830185.2010.529976
    [26] Howell J, Angus P, Gow P, et al. (2013) Toll-like receptors in hepatitis C infection: Implications for pathogenesis and treatment. J Gastroen Hepatol 28: 766-776. doi: 10.1111/jgh.12170
    [27] Liu G, Zhao Y (2007) Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 122: 149-156. doi: 10.1111/j.1365-2567.2007.02651.x
    [28] Yao C, Oh JH, Lee DH, et al. (2015) Toll-like receptor family members in skin fibroblasts are functional and have a higher expression compared to skin keratinocytes. Int J Mol Med 35: 1443-1450. doi: 10.3892/ijmm.2015.2146
    [29] Price AE, Shamardani K, Lugo KA, et al. (2018) A map of toll-like receptor expression in the intestinal epithelium reveals distinct spatial, cell type-specific, and temporal patterns. Immunity 49: 560-575. doi: 10.1016/j.immuni.2018.07.016
    [30] Yamamoto M, Sato S, Hemmi H, et al. (2003) TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4: 1144-1150. doi: 10.1038/ni986
    [31] Yamamoto M, Sato S, Hemmi H, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643. doi: 10.1126/science.1087262
    [32] Meier A, Alter G, Frahm N, et al. (2007) MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 81: 8180-8191. doi: 10.1128/JVI.00421-07
    [33] Cronin JG, Turner ML, Goetze L, et al. (2012) Toll-like receptor 4 and MYD88-dependent signaling mechanisms of the innate immune system are essential for the response to lipopolysaccharide by epithelial and stromal cells of the bovine endometrium. Biol Reprod 86: 51. doi: 10.1095/biolreprod.111.092718
    [34] Kawagoe T, Sato S, Matsushita K, et al. (2008) Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2. Nat Immunol 9: 684. doi: 10.1038/ni.1606
    [35] Kawai T, Akira S (2007) Signaling to NF-κB by Toll-like receptors. Trends Mol Med 13: 460-469. doi: 10.1016/j.molmed.2007.09.002
    [36] Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511. doi: 10.1038/nri1391
    [37] Adhikari A, Xu M, Chen ZJ (2007) Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26: 3214-3226. doi: 10.1038/sj.onc.1210413
    [38] Chen F, Bhatia D, Chang Q, et al. (2006) Finding NEMO by K63-linked polyubiquitin chain. Cell Death Differ 13: 1835. doi: 10.1038/sj.cdd.4402014
    [39] Anwar MA, Basith S, Choi S (2013) Negative regulatory approaches to the attenuation of Toll-like receptor signaling. Exp Mol Med 45: e11-e11. doi: 10.1038/emm.2013.28
    [40] Bibeau-Poirier A, Servant MJ (2008) Roles of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling. Cytokine 43: 359-367. doi: 10.1016/j.cyto.2008.07.012
    [41] Wang C, Chen T, Zhang J, et al. (2009) The E3 ubiquitin ligase Nrdp1 ‘preferentially’ promotes TLR-mediated production of type I interferon. Nat Immunol 10: 744-752. doi: 10.1038/ni.1742
    [42] Wang T, Chuang TH, Ronni T, et al. (2006) Flightless I homolog negatively modulates the TLR pathway. J Immunol 176: 1355-1362. doi: 10.4049/jimmunol.176.3.1355
    [43] Chen Z, Zhou R, Zhang Y, et al. (2020) β-arrestin 2 quenches TLR signaling to facilitate the immune evasion of EPEC. Gut Microbes 11: 1423-1437. doi: 10.1080/19490976.2020.1759490
    [44] Kobayashi K, Hernandez LD, Galán JE, et al. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202. doi: 10.1016/S0092-8674(02)00827-9
    [45] Al-Shaghdali K, Durante B, Hayward C, et al. (2019) Macrophage subsets exhibit distinct E. coli-LPS tolerisable cytokines associated with the negative regulators, IRAK-M and Tollip. PLoS One 14: e0214681. doi: 10.1371/journal.pone.0214681
    [46] Jiang S, Li X, Hess NJ, et al. (2016) TLR10 is a negative regulator of both MyD88-dependent and-independent TLR signaling. J Immunol 196: 3834-3841. doi: 10.4049/jimmunol.1502599
    [47] Olmos-Ortiz A, Déciga-García M, Preciado-Martínez E, et al. (2019) Prolactin decreases LPS-induced inflammatory cytokines by inhibiting TLR-4/NFκB signaling in the human placenta. Mol Hum Reprod 25: 660-667. doi: 10.1093/molehr/gaz038
    [48] Cao Y, Sun Y, Chang H, et al. (2019) The E3 ubiquitin ligase RNF 182 inhibits TLR-triggered cytokine production through promoting p65 ubiquitination and degradation. FEBS Lett 593: 3210-3219. doi: 10.1002/1873-3468.13583
    [49] Song Y, Li P, Qin L, et al. (2021) CUL4B negatively regulates Toll-like receptor-triggered proinflammatory responses by repressing Pten transcription. Cell Mol Immunol 18: 339-349. doi: 10.1038/s41423-019-0323-0
    [50] Lou Y, Han M, Liu H, et al. (2020) Essential roles of S100A10 in Toll-like receptor signaling and immunity to infection. Cell Mol Immunol 17: 1053-1062. doi: 10.1038/s41423-019-0278-1
    [51] Hu YH, Wang Y, Wang F, et al. (2020) SPOP negatively regulates Toll-like receptor-induced inflammation by disrupting MyD88 self-association. Cell Mol Immunol In press.
    [52] Jiang G, Gong M, Song H, et al. (2020) Tob2 Inhibits TLR-Induced Inflammatory Responses by Association with TRAF6 and MyD88. J Immunol 205: 981-986. doi: 10.4049/jimmunol.2000057
    [53] Miyake K, Yamashita Y, Ogata M, et al. (1995) RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J Immunol 154: 3333-3340.
    [54] Divanovic S, Trompette A, Atabani SF, et al. (2005) Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 6: 571-578. doi: 10.1038/ni1198
    [55] Kimoto M, Nagasawa K, Miyake K (2003) Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide. Scand J Infect Dis 35: 568-572. doi: 10.1080/00365540310015700
    [56] Ogata H, Su I, Miyake K, et al. (2000) The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med 192: 23-30. doi: 10.1084/jem.192.1.23
    [57] Nagai Y, Shimazu R, Ogata H, et al. (2002) Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99: 1699-1705. doi: 10.1182/blood.V99.5.1699
    [58] Miyake K, Yamashita Y, Hitoshi Y, et al. (1994) Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med 180: 1217-1224. doi: 10.1084/jem.180.4.1217
    [59] Chan VWF, Mecklenbräuker I, Su I, et al. (1998) The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J Exp Med 188: 93-101. doi: 10.1084/jem.188.1.93
    [60] Grumont RJ, Rourke IJ, O'Reilly LA, et al. (1998) B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med 187: 663-674. doi: 10.1084/jem.187.5.663
    [61] Lardenoye JHP, Delsing DJM, De Vries MR, et al. (2000) Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice. Circ Res 87: 248-253. doi: 10.1161/01.RES.87.3.248
    [62] Allen JL, Flick LM, Divanovic S, et al. (2012) Cutting edge: regulation of TLR4-driven B cell proliferation by RP105 is not B cell autonomous. J Immunol 188: 2065-2069. doi: 10.4049/jimmunol.1103282
    [63] Karper JC, Ewing MM, de Vries MR, et al. (2013) TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation. PLoS One 8: e67923. doi: 10.1371/journal.pone.0067923
    [64] Karper JC, de Jager SCA, Ewing MM, et al. (2013) An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation. Arterioscl Throm Vas 33: 2810-2817. doi: 10.1161/ATVBAHA.113.301882
    [65] Wezel A, van der Velden D, Maassen JM, et al. (2015) RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner. Atherosclerosis 238: 132-139. doi: 10.1016/j.atherosclerosis.2014.11.020
    [66] Wezel A, De Vries MR, Maassen JM, et al. (2016) Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response. Sci Rep 6: 1-13. doi: 10.1038/srep24248
    [67] Yang J, Zeng P, Yang J, et al. (2019) The Role of RP105 in cardiovascular disease through regulating TLR4 and PI3K signaling pathways. Curr Med Sci 39: 185-189. doi: 10.1007/s11596-019-2017-3
    [68] Yang J, Guo X, Yang J, et al. (2015) RP105 protects against apoptosis in ischemia/reperfusion-induced myocardial damage in rats by suppressing TLR4-mediated signaling pathways. Cell Physiol Biochem 36: 2137-2148. doi: 10.1159/000430180
    [69] Li X, Yang J, Yang J, et al. (2016) RP105 protects against myocardial ischemia–reperfusion injury via suppressing TLR4 signaling pathways in rat model. Exp Mol Pathol 100: 281-286. doi: 10.1016/j.yexmp.2015.12.016
    [70] Xiong X, Liu Y, Mei Y, et al. (2017) Novel protective role of myeloid differentiation 1 in pathological cardiac remodelling. Sci Rep 7: 1-13. doi: 10.1038/s41598-016-0028-x
    [71] Guo X, Jiang H, Yang J, et al. (2016) Radioprotective 105 kDa protein attenuates ischemia/reperfusion-induced myocardial apoptosis and autophagy by inhibiting the activation of the TLR4/NF-κB signaling pathway in rats. Int J Mol Med 38: 885-893. doi: 10.3892/ijmm.2016.2686
    [72] Guo X, Jiang H, Chen J, et al. (2018) RP105 ameliorates hypoxia/reoxygenation injury in cardiac microvascular endothelial cells by suppressing TLR4/MAPKs/NF-κB signaling. Int J Mol Med 42: 505-513.
    [73] Yang Y, Yang J, Liu X, et al. (2018) Down-regulation of miR-327 alleviates ischemia/reperfusion-induced myocardial damage by targeting RP105. Cell Physiol Biochem 49: 1090-1104. doi: 10.1159/000493288
    [74] Qin Q, Cui L, Zhou Z, et al. (2019) Inhibition of microRNA-141-3p reduces hypoxia-induced apoptosis in H9c2 rat cardiomyocytes by activating the RP105-dependent PI3K/AKT signaling pathway. Med Sci Monit 25: 7016. doi: 10.12659/MSM.916361
    [75] Sun Y, Liu L, Yuan J, et al. (2018) RP105 protects PC12 cells from oxygen–glucose deprivation/reoxygenation injury via activation of the PI3K/AKT signaling pathway. Int J Mol Med 41: 3081-3089.
    [76] Yu CH, Micaroni M, Puyskens A, et al. (2015) RP105 engages phosphatidylinositol 3-kinase p110δ to facilitate the trafficking and secretion of cytokines in macrophages during mycobacterial infection. J Immunol 195: 3890-3900. doi: 10.4049/jimmunol.1500017
    [77] Yazawa N, Fujimoto M, Sato S, et al. (2003) CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. Blood 102: 1374-1380. doi: 10.1182/blood-2002-11-3573
    [78] Honda Y, Yamagiwa S, Matsuda Y, et al. (2007) Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis. J Hepatol 47: 404-411. doi: 10.1016/j.jhep.2007.03.012
    [79] Zhang Z, La Placa D, Nguyen T, et al. (2019) CEACAM1 regulates the IL-6 mediated fever response to LPS through the RP105 receptor in murine monocytes. BMC Immunol 20: 1-16. doi: 10.1186/s12865-018-0284-6
    [80] Koarada S, Tada Y, Ushiyama O, et al. (1999) B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus. Arthritis Rheum 42: 2593-2600. doi: 10.1002/1529-0131(199912)42:12<2593::AID-ANR12>3.0.CO;2-G
    [81] Kikuchi Y, Koarada S, Tada Y, et al. (2001) Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells. Ann Rheum Dis 60: 1137-1140. doi: 10.1136/ard.60.12.1137
    [82] Koarada S, Tada Y, Kikuchi Y, et al. (2001) CD180 (RP105) in rheumatic diseases. Rheumatology 40: 1315-1316. doi: 10.1093/rheumatology/40.11.1315
    [83] Koarada S, Tada Y (2012) RP105-negative B cells in systemic lupus erythematosus. Clin Dev Immunol 2012: 1-5.
    [84] Koarada S, Tada Y, Suematsu R, et al. (2012) Phenotyping of P105-negative B cell subsets in patients with systemic lupus erythematosus. Clin Dev Immunol 2012: 1-8.
    [85] Korganow AS, Knapp AM, Nehme-Schuster H, et al. (2010) Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression. J Autoimmun 34: 426-434. doi: 10.1016/j.jaut.2009.11.002
    [86] Erdő-Bonyár S, Rapp J, Minier T, et al. (2019) Toll-Like receptor mediated activation of natural autoantibody producing b cell subpopulations in an autoimmune disease model. Int J Mol Sci 20: 6152. doi: 10.3390/ijms20246152
    [87] Harhaj EW, Dixit VM (2012) Regulation of NF-κB by deubiquitinases. Immunol Rev 246: 107-124. doi: 10.1111/j.1600-065X.2012.01100.x
    [88] Aksentijevich I, Zhou Q (2017) NF-κB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol 8: 399. doi: 10.3389/fimmu.2017.00399
    [89] Keusekotten K, Elliott PR, Glockner L, et al. (2013) OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 153: 1312-1326. doi: 10.1016/j.cell.2013.05.014
    [90] Dixit VM, Green S, Sarma V, et al. (1990) Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 265: 2973-2978. doi: 10.1016/S0021-9258(19)39896-5
    [91] Kinsella S, Fichtner M, Watters O, et al. (2018) Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation. J Neuroinflammation 15: 1-12. doi: 10.1186/s12974-018-1143-3
    [92] Bhattacharyya S, Varga J (2018) Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy. Immunol Lett 195: 9-17. doi: 10.1016/j.imlet.2017.09.011
    [93] Feng H, Pyykkö I, Zou J (2016) Involvement of ubiquitin-editing protein A20 in modulating inflammation in rat cochlea associated with silver nanoparticle-induced CD68 upregulation and TLR4 activation. Nanoscale Res Lett 11: 1-13. doi: 10.1186/s11671-015-1209-4
    [94] Krikos A, Laherty CD, Dixit VM (1992) Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem 267: 17971-17976. doi: 10.1016/S0021-9258(19)37138-8
    [95] Opipari AW, Boguski MS, Dixit VM (1990) The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 265: 14705-14708. doi: 10.1016/S0021-9258(18)77165-2
    [96] Catrysse L, Vereecke L, Beyaert R, et al. (2014) A20 in inflammation and autoimmunity. Trends Immunol 35: 22-31. doi: 10.1016/j.it.2013.10.005
    [97] Lee EG, Boone DL, Chai S, et al. (2000) Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289: 2350-2354. doi: 10.1126/science.289.5488.2350
    [98] Lu TT, Onizawa M, Hammer GE, et al. (2013) Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. Immunity 38: 896-905. doi: 10.1016/j.immuni.2013.03.008
    [99] Wertz IE, O'rourke KM, Zhou H, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430: 694-699. doi: 10.1038/nature02794
    [100] Wertz IE, Newton K, Seshasayee D, et al. (2015) Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 528: 370-375. doi: 10.1038/nature16165
    [101] Mauro C, Pacifico F, Lavorgna A, et al. (2006) ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB. J Biol Chem 281: 18482-18488. doi: 10.1074/jbc.M601502200
    [102] Ha H, Han D, Choi Y (2009) TRAF-mediated TNFR-family signaling. Curr Protoc Immunol 87: 11.
    [103] Heyninck K, Beyaert R (1999) The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-κB activation at the level of TRAF6. FEBS Lett 442: 147-150. doi: 10.1016/S0014-5793(98)01645-7
    [104] De A, Dainichi T, Rathinam CV, et al. (2014) The deubiquitinase activity of A 20 is dispensable for NF-κ B signaling. EMBO Rep 15: 775-783. doi: 10.15252/embr.201338305
    [105] Boone DL, Turer EE, Lee EG, et al. (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5: 1052-1060. doi: 10.1038/ni1110
    [106] Harhaj EW, Dixit VM (2011) Deubiquitinases in the regulation of NF-κB signaling. Cell Res 21: 22-39. doi: 10.1038/cr.2010.166
    [107] Lin FT, Lin VY, Lin VTG, et al. (2016) TRIP6 antagonizes the recruitment of A20 and CYLD to TRAF6 to promote the LPA2 receptor-mediated TRAF6 activation. Cell Discovery 2: 1-22.
    [108] Saitoh T, Yamamoto M, Miyagishi M, et al. (2005) A20 is a negative regulator of IFN regulatory factor 3 signaling. J Immunol 174: 1507-1512. doi: 10.4049/jimmunol.174.3.1507
    [109] Feoktistova M, Makarov R, Brenji S, et al. (2020) A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes. Cells 9: 351. doi: 10.3390/cells9020351
    [110] Li L, Huang B, Song S, et al. (2017) A20 functions as mediator in TNFα-induced injury of human umbilical vein endothelial cells through TAK1-dependent MAPK/eNOS pathway. Oncotarget 8: 65230. doi: 10.18632/oncotarget.18191
    [111] Li Y, Mooney EC, Holden SE, et al. (2019) A20 orchestrates inflammatory response in the oral mucosa through restraining NF-κB activity. J Immunol 202: 2044-2056. doi: 10.4049/jimmunol.1801286
    [112] Li Y, Mooney EC, Xia XJ, et al. (2020) A20 restricts inflammatory response and desensitizes gingival keratinocytes to apoptosis. Front Immunol 11: 365. doi: 10.3389/fimmu.2020.00365
    [113] Martens A, Priem D, Hoste E, et al. (2020) Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities. Nat Immunol 21: 381-387. doi: 10.1038/s41590-020-0621-9
    [114] Soni D, Wang DM, Regmi SC, et al. (2018) Deubiquitinase function of A20 maintains and repairs endothelial barrier after lung vascular injury. Cell Death Discovery 4: 1-14. doi: 10.1038/s41420-018-0056-3
    [115] Mohebiany AN, Ramphal NS, Karram K, et al. (2020) Microglial A20 protects the brain from CD8 T-cell-mediated immunopathology. Cell Rep 30: 1585-1597. doi: 10.1016/j.celrep.2019.12.097
    [116] Ma A, Malynn BA (2012) A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol 12: 774-785. doi: 10.1038/nri3313
    [117] Malynn BA, Ma A (2019) A20: a multifunctional tool for regulating immunity and preventing disease. Cell Immunol 340: 103914. doi: 10.1016/j.cellimm.2019.04.002
    [118] Hövelmeyer N, Reissig S, Thi Xuan N, et al. (2011) A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol 41: 595-601. doi: 10.1002/eji.201041313
    [119] Tavares RM, Turer EE, Liu CL, et al. (2010) The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 33: 181-191. doi: 10.1016/j.immuni.2010.07.017
    [120] Chu Y, Vahl JC, Kumar D, et al. (2011) B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood 117: 2227-2236. doi: 10.1182/blood-2010-09-306019
    [121] Hammer GE, Turer EE, Taylor KE, et al. (2011) Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol 12: 1184-1193. doi: 10.1038/ni.2135
    [122] Matmati M, Jacques P, Maelfait J, et al. (2011) A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 43: 908-912. doi: 10.1038/ng.874
    [123] Vereecke L, Sze M, Guire CM, et al. (2010) Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis. J Exp Med 207: 1513-1523. doi: 10.1084/jem.20092474
    [124] Mooney EC, Sahingur SE (2021) The ubiquitin system and A20: implications in health and disease. J Dent Res 100: 10-20. doi: 10.1177/0022034520949486
    [125] Razani B, Whang MI, Kim FS, et al. (2020) Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis–like disease and inflammation. Nat Immunol 21: 422-433. doi: 10.1038/s41590-020-0634-4
    [126] Yoon CI, Ahn SG, Bae SJ, et al. (2019) High A20 expression negatively impacts survival in patients with breast cancer. PLoS One 14: e0221721. doi: 10.1371/journal.pone.0221721
    [127] Lee YH, Song GG (2012) Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis. Genet Test Mol Biomarkers 16: 1105-1110. doi: 10.1089/gtmb.2012.0096
    [128] Korman BD, Criswell LA (2015) Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance. Curr Rheumatol Rep 17: 1-11. doi: 10.1007/s11926-014-0484-x
    [129] Mayes MD, Bossini-Castillo L, Gorlova O, et al. (2014) Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet 94: 47-61. doi: 10.1016/j.ajhg.2013.12.002
    [130] Martin JE, Assassi S, Diaz-Gallo LM, et al. (2013) A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet 22: 4021-4029. doi: 10.1093/hmg/ddt248
    [131] Dieude P, Guedj M, Wipff J, et al. (2010) Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 69: 1958-1964. doi: 10.1136/ard.2009.127928
    [132] Koumakis E, Giraud M, Dieudé P, et al. (2013) SAT0013 Candidate gene study in systemic sclerosis identifies a rare and functional variant of TNFAIP3 locus as a risk factor for individual polyautoimmunity. Ann Rheum Dis 71: 475-475. doi: 10.1136/annrheumdis-2012-eular.1670
    [133] Liu Y, Ye Z, Li X, et al. (2017) Genetic and functional associations with decreased anti-inflammatory tumor necrosis factor alpha induced protein 3 in macrophages from subjects with axial spondyloarthritis. Front Immunol 8: 860. doi: 10.3389/fimmu.2017.00860
    [134] Sun YY, Fan YC, Wang N, et al. (2015) Increased A20 mRNA level in peripheral blood mononuclear cells is associated with immune phases of patients with chronic hepatitis B. Medicine 94: e2428. doi: 10.1097/MD.0000000000002428
    [135] Xu H, Wang L, Zheng P, et al. (2017) Elevated serum A20 is associated with severity of chronic hepatitis B and A20 inhibits NF-κB-mediated inflammatory response. Oncotarget 8: 38914. doi: 10.18632/oncotarget.17153
    [136] Hung YY, Lin CC, Kang HY, et al. (2017) TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder. Brain Behav Immun 59: 265-272. doi: 10.1016/j.bbi.2016.09.014
    [137] Huang H, Tang QZ, Wang AB, et al. (2010) Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-β-activated kinase 1-dependent signaling. Hypertension 56: 232-239. doi: 10.1161/HYPERTENSIONAHA.110.149963
    [138] Xu W, Wang C, Liang M, et al. (2018) A20 prevents obesity-induced development of cardiac dysfunction. J Mol Med 96: 159-172. doi: 10.1007/s00109-017-1608-3
    [139] Jung SM, Lee JH, Park J, et al. (2013) Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat Commun 4: 1-16.
    [140] Liu S, Lv X, Liu C, et al. (2019) Targeting degradation of the transcription factor C/EBPβ reduces lung fibrosis by restoring activity of the ubiquitin-editing enzyme A20 in macrophages. Immunity 51: 522-534. doi: 10.1016/j.immuni.2019.06.014
    [141] Wang X, Ai L, Xu Q, et al. (2017) A20 attenuates liver fibrosis in NAFLD and inhibits inflammation responses. Inflammation 40: 840-848. doi: 10.1007/s10753-017-0528-2
    [142] Kelly C, Reihill J, Malconsom B, et al. (2013) Defective A20 signalling in CF: Anti-inflammatory action of gibberellins. Eur Respir J 42: 2106.
    [143] Malcomson B, Wilson H, Veglia E, et al. (2016) Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis. P Natl Acad Sci USA 113: E3725-E3734. doi: 10.1073/pnas.1520289113
    [144] Bhattacharyya S, Wang W, Graham LVD, et al. (2016) A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator. Arthritis Res Ther 18: 1-10. doi: 10.1186/s13075-016-1118-7
    [145] Hand LE, Usan P, Cooper GJS, et al. (2015) Adiponectin induces A20 expression in adipose tissue to confer metabolic benefit. Diabetes 64: 128-136. doi: 10.2337/db13-1835
    [146] Carrion AM, Link WA, Ledo F, et al. (1999) DREAM is a Ca2+-regulated transcriptional repressor. Nature 398: 80-84. doi: 10.1038/18044
    [147] Cebolla B, Fernández-Pérez A, Perea G, et al. (2008) DREAM mediates cAMP-dependent, Ca2+-induced stimulation of GFAP gene expression and regulates cortical astrogliogenesis. J Neurosci 28: 6703-6713. doi: 10.1523/JNEUROSCI.0215-08.2008
    [148] Savignac M, Mellström B, Bébin AG, et al. (2010) Increased B cell proliferation and reduced Ig production in DREAM transgenic mice. J Immunol 185: 7527-7536. doi: 10.4049/jimmunol.1000152
    [149] Tiruppathi C, Soni D, Wang DM, et al. (2014) The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation. Nat Immunol 15: 239-247. doi: 10.1038/ni.2823
    [150] Naranjo JR, Zhang H, Villar D, et al. (2016) Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease. J Clin Invest 126: 627-638. doi: 10.1172/JCI82670
    [151] Lopez-Hurtado A, Peraza DA, Cercos P, et al. (2019) Targeting the neuronal calcium sensor DReAM with small-molecules for Huntington's disease treatment. Sci Rep 9: 1-16. doi: 10.1038/s41598-019-43677-7
    [152] Bhattacharyya S, Wang W, Tamaki Z, et al. (2018) Pharmacological inhibition of toll-like receptor-4 signaling by TAK242 prevents and induces regression of experimental organ fibrosis. Front Immunol 9: 2434. doi: 10.3389/fimmu.2018.02434
    [153] Bhattacharyya S, Wang W, Graham LVD, et al. (2016) A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator. Arthritis Res Ther 18: 1-10. doi: 10.1186/s13075-016-1118-7
  • This article has been cited by:

    1. Xin Du, Quansheng Liu, Yuanhong Bi, Bifurcation analysis of a two–dimensional p53 gene regulatory network without and with time delay, 2023, 32, 2688-1594, 293, 10.3934/era.2024014
    2. Huazhou Mo, Yuanfu Shao, Stability and bifurcation analysis of a delayed stage-structured predator–prey model with fear, additional food, and cooperative behavior in both species, 2025, 2025, 2731-4235, 10.1186/s13662-025-03879-y
  • Reader Comments
  • © 2021 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(4397) PDF downloads(188) Cited by(4)

Figures and Tables

Figures(3)  /  Tables(1)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog